![Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) - Digestive and Liver Disease Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) - Digestive and Liver Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/04d3e5a3-f942-47dd-b803-7d66fd372d14/gr1_lrg.jpg)
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) - Digestive and Liver Disease
![PDF) Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9 PDF) Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9](https://i1.rgstatic.net/publication/21415409_Sensitivity_and_specificity_of_CA242_in_gastro-intestinal_cancer_A_comparison_with_CEA_CA50_and_CA_19-9/links/556ee45a08aec2268308fe12/largepreview.png)
PDF) Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9
![Cancers | Free Full-Text | Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer | HTML Cancers | Free Full-Text | Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer | HTML](https://www.mdpi.com/cancers/cancers-12-03234/article_deploy/html/images/cancers-12-03234-g001.png)
Cancers | Free Full-Text | Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer | HTML
![Download PDF | Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases Download PDF | Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases](https://i1.rgstatic.net/publication/21133561_Comparison_of_a_new_tumour_marker_CA_242_with_CA_19-9_CA_50_and_carcinoembryonic_antigen_CEA_in_digestive_tract_diseases/links/0c96051753be1552b3000000/largepreview.png)
Download PDF | Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases
Detection of Classic Serum Tumor Markers (CSTMs) Group Bene ts to Differential Diagnosis and Disease Assessment of UTUC
![Frontiers | CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer Frontiers | CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer](https://www.frontiersin.org/files/Articles/644933/fonc-11-644933-HTML/image_m/fonc-11-644933-g001.jpg)
Frontiers | CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer
![Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy | Science Translational Medicine Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aal3226/asset/339c3103-2920-46af-ba90-0e76dc54378b/assets/graphic/aal3226-f1.jpeg)
Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy | Science Translational Medicine
![ESMO17. STUDIU: Determinarea în exces a markerilor tumorali produce anxietate pacienților și determină costuri inutile ESMO17. STUDIU: Determinarea în exces a markerilor tumorali produce anxietate pacienților și determină costuri inutile](https://raportuldegarda.ro/wp-content/uploads/2017/09/markeri_tumori_localizare.jpg)
ESMO17. STUDIU: Determinarea în exces a markerilor tumorali produce anxietate pacienților și determină costuri inutile
![Diagnostics | Free Full-Text | Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer | HTML Diagnostics | Free Full-Text | Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer | HTML](https://www.mdpi.com/diagnostics/diagnostics-12-00286/article_deploy/html/images/diagnostics-12-00286-g001.png)
Diagnostics | Free Full-Text | Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer | HTML
![ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour–stromal IL-1β/NF–κB/ESE3 signalling axis | British Journal of Cancer ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour–stromal IL-1β/NF–κB/ESE3 signalling axis | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01927-y/MediaObjects/41416_2022_1927_Fig1_HTML.png)